

Cover Story
FreeHealth Equity
By Matthew Bin Han Ong
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
In Brief
Clinical Roundup
Drugs & Targets


NCI Trials


NCI Trials for July 2021
The National Cancer Institute approved the following clinical research studies last month. For further information, contact the principal investigator listed.
Trending Stories
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- How George Tidmarsh crossed the FDA-industry Rubicon
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA















